CoChat

Sexual dysfunction associated with major depressive disorder and antidepressant treatment

Clayton, Anita H, El Haddad, Saria, Iluonakhamhe, Josepha-Pearl, Ponce Martinez, Caridad, Schuck, Alexandra Elizabeth · 2014 · Expert Opinion on Drug Safety
Cited by 128

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: There is a well-established relationship between sexual functioning and quality of life. Depression can cause sexual dysfunction (SD) and its treatment can often lead to restoration of sexual functioning. Use of antidepressants has also been associated with SD, with implications for treatment compliance and creation of further distress for the patient. AREAS COVERED: This review evaluates available information regarding SD related to both depression and antidepressant treatment, including literature up to June 2014. It includes eligible published studies that investigated antidepressant-associated SD (AASD). EXPERT OPINION: Depression and SD have a bidirectional association. When screening for depression, baseline sexual functioning should be assessed with validated rating scales. If sexual side effects develop with antidepressant treatment, management options include waiting for spontaneous remission, decreasing the medication dose, switching to an alternative drug or adding an augmentation agent or antidote. Research suggests that bupropion and newer antidepressants exhibit a more favorable SD profile compared with other antidepressants, especially selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors. Bupropion, mirtazapine and buspirone have been studied as augmentation agents/antidotes or substitution agents in management of AASD. Future studies validating genetic factors could enable personal genotyping to guide individualized treatment and also facilitate the development of enhanced therapeutic guidelines to avoid or manage AASD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/14740338.2014.951324

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 128

Metadata

Authors
Clayton, A. H., El Haddad, S., Iluonakhamhe, J.-P., Ponce Martinez, C., & Schuck, A. E.
Venue
Expert Opinion on Drug Safety
Published
2014-08-22
Volume
13
Issue
10
Pages
1361-1374
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W2073741345
Cited by
128
References
16
FWCI
5.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sexual dysfunction associated with major depressive disorder and antidepressant treatment. https://app.cochat.ai/papers/10.1517/14740338.2014.951324
The paper
Clayton, A. H., El Haddad, S., Iluonakhamhe, J.-P., Ponce Martinez, C., & Schuck, A. E. (2014). Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2014.951324

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.